Premium
Clinical, imaging, and molecular findings in a sample of Mexican families with pantothenate kinase‐associated neurodegeneration
Author(s) -
MoralesBriceño H.,
ChacónCamacho O.F.,
PérezGonzález E.A.,
ArteagaVázquez J.,
RodríguezViolante M.,
CervantesArriaga A.,
PérezRodríguez L.,
Zenteno J.C.,
Mutchinick O.M.
Publication year - 2015
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.12400
Subject(s) - parkinsonism , dystonia , neurodegeneration , compound heterozygosity , genetics , mutation , lrrk2 , disease , biology , medicine , pathology , gene , neuroscience
Pantothenate kinase‐associated neurodegeneration ( PKAN ) is an autosomal recessive disorder characterized by iron accumulation in the brain, because of mutations in the PANK2 gene. Phenotypic and genotypic characteristics of 11 patients from five Mexican families with PKAN disease are reported. Sequencing of PANK2 confirmed the diagnosis. The 11 patients had dysarthria associated with dystonia and Parkinsonism in six. Brain magnetic resonance imaging ( MRI ) showed the ‘eye‐of‐the‐tiger’ sign in all patients. Three different mutations were identified, a novel one (p. A469P ) and two (p. G219V and p. N404I ) very rare. Homozygous sibs for the p. G219V mutation had a severe disease progression with early death. Dystonia predominated in the p. A469P /p. N404I compound heterozygous patients. Homozygous for p. N404I showed Parkinsonism, tics and personality and speech disorders. Early and late disease onset and variable expression was present in carriers of the different identified mutations. The ‘eye‐of‐the‐tiger’ is an excellent neuroimaging hallmark to predict PANK2 mutations. We detected a ‘cluster’ of patients harboring the p. N404I mutation, strongly suggesting a founder effect for this mutation. This is the first familial clinical‐genetic PKAN disease study accomplished in Mexico.